Emerging immune networks and targeted strategies in T2 asthma - Takeaways - MDSpire

Novel Immune Pathways and Targeted Approaches in Type 2 Asthma

  • By

  • Tianye Xi

  • Tingting Zu

  • Xinru Pang

  • Fuling Wu

  • July 17, 2026

Share

  • 1

    Type 2 asthma is characterized by a complex immune network involving Th2 cells, ILC2s, and Tc2 cells.

  • 2

    Epithelial-derived alarmins IL-33 and TSLP are key initiators that connect innate and adaptive immunity in T2 asthma.

  • 3

    Th2-high asthma accounts for 50%-70% of cases, particularly prevalent in pediatric populations and early-onset disease.

  • 4

    Recent advances in asthma research highlight the need for precision medicine targeting upstream alarmins rather than downstream effectors.

  • 5

    Th2 cells are now recognized as a heterogeneous population with distinct subsets, including pathogenic effector Th2 and tissue-resident memory Th2 cells.

Original Source(s)

Emerging immune networks and targeted strategies in T2 asthma

  • by Tianye Xi, Tingting Zu, Xinru Pang, Fuling Wu

  • July 17, 2026

Related Content

FDA Expands CAPVAXIVE Pediatric Use

Phase 3 data showed noninferior immune responses vs pneumococcal 23-valent polysaccharide vaccine in pediatric patients at increased risk.

Efficacy and safety of Tuina therapy for children with combined allergic rhinitis and asthma syndrome in remission: a randomized controlled trial protocol

Hormone-dependent immune regulation shapes asthma heterogeneity across the female lifespan